Migraine Pharmacotherapy, 2023 Update
-
Register
- User - $40
Update on treatment of migraines utilizing case studies.
Credits: 1.50 Contact Hours; 1.50 are Pharmacology
Expiration Date: December 31st, 2025
$40
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Develop a strategy to diagnose migraine headache and guide to treatment
-Recognize mechanism of action and clinical profiles of therapeutic options for acute and preventative treatment
-Apply evidence-based research to guide pharmacology selection
Angela Golden, DNP, FNP-C, FAANP
Owner and Provider
NP From Home, LLC
Dr. Angela Golden, is a current fellow and past president of the American Association of Nurse Practitioners. Her tenure as the president of the AANP gives her a unique and overarching perspective of the multifunctional role of the Nurse Practitioner. For the past 26 years, Angie has had her own practice—NP from Home, LLC—where she provides clinical services in a family practice and for the past 7 years a subspecialty obesity practice, NP Obesity Treatment Clinic
Angie has a great deal of experience in leadership positions and clinical practice. She has authored peer-reviewed articles and book chapters covering a range of health topics including health policy. She has presented nationally and internationally with an emphasis on health policy, leadership, and various clinical topics
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Angie Golden, DNP, FNP-C, FAANP, FOMA has disclosed.
Novo Nordisk: Obesity - Promotional speaker & Advisory boardAcella: Thyroid - Advisory board & Promotional speaker Gelesis: Obesity - Advisory board
Currax: Obesity - Advisory board & Promotional speaker
Lilly: Obesity and Sleep apnea - Advisory Board
WW: Obesity - Advisory board
SetPoint: Obesity - Advisor
Springer: Obesity - Author
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.